Action is taken to increase the safety and appropriateness of prescribing and clinically using blood and blood products
- Ensuring Supply
- Overview: Ensuring Supply
- What Blood Products are Supplied - National Product Price List
- Supply Planning and Management
- Changes to National Product Price List
- Contracts with Suppliers
- Supply to Australians Overseas
- Risk Management
- Blood Product Management
- Transition of Australia's Domestic Plasma Products: What you need to do to start preparing
- Australian Health Provider Blood and Blood Products Charter
- Best Practice
- National Standard
- Case Studies
- Pathology Queensland Case Study
- NSW Health Pathology – North (Hunter) Case Study
- SAN Pathology Case Study
- BloodMove Project Case Study
- BloodMove Platelets - Case Study
- Burnside War Memorial Hospital Case Study
- The Royal Children's Hospital Melbourne Extended Life Plasma Protocol Case Study
- Preoperative Anaemia Identification, Assessment and Management Case Study
- Point of Care Coagulation Testing Case Study
- Liverpool Hospital RFID Case Study
- Stewardship
- Patient Blood Management
- PBM Guidelines
- Patient blood management guideline for adults with critical bleeding
- Patient blood management guideline for adults with critical bleeding
- Module 2 Perioperative
- Module 3 Medical
- Module 4 Critical Care
- Module 5 Obstetrics and Maternity
- Module 6 Neonatal and Paediatrics
- PBM Guidelines Progress Updates
- PBM Guidelines Launch
- Implementing Patient Blood Management
- Supporting Patients in PBM Decision Making
- PBM Guidelines
- Immunoglobulin (Ig)
- National Immunoglobulin Governance Program
- National Policy: Immunoglobulin
- National Immunoglobulin Governance Committees
- National Immunoglobulin Governance Program Performance Improvement Strategy 2019-2022
- Criteria for the Clinical Use of Immunoglobulin in Australia
- Version 3 of the Criteria! (page under review)
- Ig Program Updates
- Ig usage data and statistics
- Access to Intravenous Immunoglobulin (IVIg)
- Access to Subcutaneous Immunoglobulin (SCIg)
- Ig Access Outside of the National Blood Arrangements
- Access to Normal Human Immunoglobulin (NHIg)
- BloodSTAR
- BloodSTAR Privacy Controls
- Ig Resources – for patients and health professionals
- Review of the Authorisation and Clinical Governance Framework for Intravenous Immunoglobulin (2012)
- Ig HTA Reviews
- Prophylactic use of Rh D immunoglobulin in maternity care
- Fresh Blood Products
- Bleeding Disorders
- Education and Training
- Haemovigilance
- NBA sponsored awards
- Blood Systems
- Overview: Blood Systems
- Blood Operations Centre
- Australian Bleeding Disorders Registry
- Big Red
- BloodNet
- BloodPortal
- Jurisdictional Reporting
- MyABDR
- Barcode Specifications
- BloodSTAR
- Data & Research
- About Blood
- Publications & Tools
Key links
Site information
Share this page
Print